These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8290915)

  • 41. Karyometry of bladder washings for the follow up of patients with transitional cell carcinoma of the bladder.
    van der Poel HG; Oosterhof GO; Schaafsma HE; Wiersma-van Tilburg A; Debruyne FM; Schalken JA
    Prog Clin Biol Res; 1992; 378():9-18. PubMed ID: 1301590
    [No Abstract]   [Full Text] [Related]  

  • 42. High-grade transitional cell carcinoma of the pediatric bladder.
    Korrect GS; Minevich EA; Sivan B
    J Pediatr Urol; 2012 Jun; 8(3):e36-8. PubMed ID: 22105002
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Tumors of the bladder. The pathologist's point of view].
    Vieillefond A; Quillard J; Ladouch-Badré A; Meduri G; Nenert M; Matani A; Martin E
    Ann Pathol; 1989; 9(4):249-64. PubMed ID: 2675865
    [No Abstract]   [Full Text] [Related]  

  • 44. Transurethral ultrasonography, fiberoptic cystoscopy and bladder washout cytology in the evaluation of bladder tumours.
    Akdaş A; Türkeri L; Ersev D; Ersev A; Kullu S
    Int Urol Nephrol; 1992; 24(5):503-8. PubMed ID: 1459827
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The proliferating nuclear fraction as a prognostic factor in superficial bladder carcinomas].
    Belloso L; Zugasti A; Urkia M; Arozena F; Blasco-Olaetxea E
    Arch Esp Urol; 1997 Oct; 50(8):831-6. PubMed ID: 9463280
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pretreatment staging of invasive transitional cell carcinoma of the bladder. American College of Radiology. ACR Appropriateness Criteria.
    Bigongiari LR; Amis ES; Bluth EI; Bush WH; Choyke PL; Fritzsche P; Holder L; Newhouse JH; Sandler CM; Segal AJ; Resnick MI; Rutsky EA
    Radiology; 2000 Jun; 215 Suppl():697-702. PubMed ID: 11037487
    [No Abstract]   [Full Text] [Related]  

  • 47. Impact of second opinion pathology in the definitive management of patients with bladder carcinoma.
    Coblentz TR; Mills SE; Theodorescu D
    Cancer; 2001 Apr; 91(7):1284-90. PubMed ID: 11283928
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Prognostic significance of dysplastic urothelial changes for the rate of recurrence in superficial urinary bladder cancer].
    Flamm J
    Z Urol Nephrol; 1987 Nov; 80(11):641-6. PubMed ID: 3439374
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of tumour grade, stage, number and size, smoking habits and sex on the recurrence rate and disease-free interval in patients with transitional cell carcinoma of the bladder.
    Raitanen MP; Tammela TL
    Ann Chir Gynaecol; 1995; 84(1):37-41. PubMed ID: 7645909
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Value of random mucosal biopsies in the management of superficial bladder cancer.
    Mufti GR; Singh M
    Eur Urol; 1992; 22(4):288-93. PubMed ID: 1490505
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Grading and staging of bladder carcinoma in transurethral resection specimens. Correlation with 105 matched cystectomy specimens.
    Cheng L; Neumann RM; Weaver AL; Cheville JC; Leibovich BC; Ramnani DM; Scherer BG; Nehra A; Zincke H; Bostwick DG
    Am J Clin Pathol; 2000 Feb; 113(2):275-9. PubMed ID: 10664630
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of 1998 WHO/ISUP and 1973 WHO classifications for interobserver variability in grading of papillary urothelial neoplasms of the bladder. Pathological evaluation of 258 cases.
    Gonul II; Poyraz A; Unsal C; Acar C; Alkibay T
    Urol Int; 2007; 78(4):338-44. PubMed ID: 17495493
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Guidelines for diagnosis of bladder cancer. German Society of Urology].
    Urologe A; 1998 Jul; 37(4):441-57. PubMed ID: 9738301
    [No Abstract]   [Full Text] [Related]  

  • 54. Reliability of CT in preoperative evaluation of bladder carcinoma.
    Nurmi M; Katevuo K; Puntala P
    Scand J Urol Nephrol; 1988; 22(2):125-8. PubMed ID: 3206216
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Transitional cell carcinoma of the prostate in cystoprostatectomy specimens].
    Liedberg F; Chebil G; Davidsson T; Malmström PU; Sherif A; Månsson W
    Aktuelle Urol; 2003 Sep; 34(5):333-6. PubMed ID: 14566661
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Significance of random biopsies of healthy mucosa in superficial bladder tumor].
    Fernández Gómez JM; Rodríguez Martínez JJ; Escaf Barmadah S; Pérez García J; García J; Casasola Chamorro J
    Arch Esp Urol; 2000 Nov; 53(9):785-97. PubMed ID: 11196385
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prediction of T1-2 GI-II transitional cell bladder cancer; evaluation by histoquantitative methods.
    Lipponen PK; Eskelinen MJ; Sotarauta M
    Scand J Urol Nephrol; 1991; 25(2):129-34. PubMed ID: 1871558
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hypocellular bladder wash specimens and their clinical significance.
    Kusuda L; Kimmel M; Fair WR; Melamed M
    J Urol; 1993 Oct; 150(4):1123-5. PubMed ID: 8371370
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bladder tumours in Chinese: a 6 year study.
    Lam KY; Chan AC; Chan KW
    Aust N Z J Surg; 1994 Aug; 64(8):551-5. PubMed ID: 8048894
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Grading of Total Mesorectal Excision Specimens: Assessment of Interrater Agreement.
    Goebel EA; Stegmaier M; Gorassini DR; Kubica M; Parfitt JR; Driman DK
    Dis Colon Rectum; 2018 Jun; 61(6):686-691. PubMed ID: 29722727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.